Navigation Links
Site Quality Management to Optimize Risk-Based and Centralized Monitoring, New Life Science Webinar Hosted by Xtalks
Date:3/27/2013

Toronto, Canada (PRWEB) March 27, 2013

In today’s clinical development environment, the quest for improved data quality at a lower cost is of paramount importance to all research organizations.

With over 30% of the cost of a clinical trial is directed to monitoring — risk-based models for monitoring have become a growing and crucial component. And recent FDA guidance has lent further support for this paradigm.

This webinar will break down the issues related to the implementation and tracking of a risk-based monitoring program through the utilization of site quality management. Expert speakers — Mr. Steve Young (Senior Director of Medidata Solutions) and Ms. Laurie Halloran (President of Halloran Consulting Group) — will summarize the general process and organizational challenges of adopting site quality management and centralized monitoring.

Webinar attendees will walk away with a strong understanding of:

  •     The role of data quality and metrics in the adoption of risk-based monitoring
  •     The regulatory agencies’ guidance on risk-based monitoring
  •     Challenges in adopting a risk-based approach
  •     The concepts underpinning a site quality management program
  •     What's needed in terms of organizational support and process change to implement risk-based monitoring with centralized site quality management

For more information about this event or to register, visit: http://xtks.in/xto586-event.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/3/prweb10567561.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. New Resource Provides Herb Industry With Sources of Quality Specifications
2. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
3. AMPAC Fine Chemicals Continues to Invest in Quality Systems
4. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
5. Quality Standards Established for Competition to Identify Best Researchers in the US
6. Clearing the air: PNNL technology wins award for improving submarine air quality
7. Promoting the States Quality of Life, New Jersey Symphony Orchestra to Perform at BIO International Convention
8. Tri-Valley Sedation Dentist Dr. Endre Selmeczy Now Offers High-quality Dental Restorations
9. Quality Salivary Research with the Salimetrics Center of Excellence Program
10. OncoSec Receives ISO 13485 Quality Management System Certification
11. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Prepare for FDA Inspections of Their Quality Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... insulin, cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or SNPs of interest) ... from Salimetrics’ SalivaLab , the relationship between insulin and other relevant biomarkers ...
(Date:2/23/2017)... and SAN FRANCISCO , ... privately-held regenerative medicine company, and Beyond Type 1, a ... type 1 diabetes, today announced a grant from Beyond ... functional cure for type 1 and other insulin-requiring diabetes.  ... has been developing innovative stem cell-derived cell replacement therapies ...
(Date:2/22/2017)... ... February 22, 2017 , ... Park Systems , a ... Luncheon for all SPIE attendees and Park customers on Feb. 27, ... from the San Jose Convention Center. The luncheon will feature a talk on ...
Breaking Biology Technology:
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
Breaking Biology News(10 mins):